Trial intelligence / Profile preview

Dexmedetomidine vs sufentanil combined with propofol for sedation-guided gastrointestinal endoscopy

ChiCTR2200057956Phase 4Completed

Sponsor
Beijing Friendship Hospital
Start
Mar 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in None comparing Dexmedetomidine + propofol with Sufentanil + propofol (2 arms). Primary endpoint: Unit propofol. Started Mar 2022; status: completed.

02

Drugs

dexmedetomidinesufentanilpropofol

Beyond the preview

Go deeper on ChiCTR2200057956.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200057956.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call